key: cord-0884911-4hz5omde
authors: Hutchinson, Noah T.; Steelman, Andrew; Woods, Jeffrey A.
title: Behavioral Strategies to Prevent and Mitigate COVID-19 Infection
date: 2020-09-10
journal: Sports medicine and health science
DOI: 10.1016/j.smhs.2020.09.001
sha: 6e6c1359d336aff595e55b902f6a28631d43793a
doc_id: 884911
cord_uid: 4hz5omde

The single stranded RNA virus SARS-CoV-2 has caused a massive addition to the already leading global cause of mortality, viral respiratory tract infections. Characterized by and associated with early and deleteriously enhanced production of pro-inflammatory cytokines by respiratory epithelial cells, severe COVID-19 illness has the potential to inflict acute respiratory distress syndrome and even death. Due to the fast spreading nature of COVID-19 and the current lack of a vaccine or specific pharmaceutical treatments, understanding of viral pathogenesis, behavioral prophylaxis, and mitigation tactics are of great public health concern. This review article outlines the immune response to viral pathogens, and due to the novelty of COVID-19 and the large body of evidence suggesting the respiratory and immune benefits from regular moderate intensity exercise, provides observational and mechanistic evidence from research on other viral infections that suggests strategically planned exercise regimens may help reduce susceptibility to infection, while also mitigating severe immune responses to infection commonly associated with poor COVID-19 prognosis. We propose that regular moderate intensity exercise should be considered as part of a combinatorial approach including widespread hygiene initiatives, properly planned and well-executed social distancing policies, and use of efficacious facial coverings like N95 respirators. Studies discerning COVID-19 pathogenesis mechanisms, transfer dynamics, and individual responses to pharmaceutical and adjunct treatments are needed to reduce viral transmission and bring an end to the COVID-19 pandemic.

Viral infections of the respiratory tract are the leading cause of mortality 1 , representing the most prevalent and pathogenic form of infectious disease in the world. There is a wide variety of respiratory viruses including rhinovirus (the common cold), the more pathogenic influenza virus, and the recently discovered and relatively unknown SARS-CoV-2. The virus was discovered in December of 2019 and the World Health Organization (WHO) characterized COVID-19 as a pandemic in March 2020 2 . According to the Worldometer, a free website dedicated to accurate reporting of statistics, as of September 1, 2020, it has infected 25,695,457 people, with 855,968 confirmed deaths 3 . Models from the University of Washington project it to take another 60,000 lives in the next four months in the U.S. 4 . Infection occurs when a person is exposed to infected aerosolized droplets or contaminated surfaces, following which the virus invades and infects the upper and/or lower respiratory mucosal tissues through interaction with the angiotensin converting enzyme 2 (ACE2) receptor on host respiratory epithelial cells.

COVID-19 seems to have a much longer duration (2-6 weeks) than typical respiratory infections 5,6 like influenza, which generally have a duration of 7-14 days. Symptomology in mild COVID-19 cases presents as traditional respiratory virus symptoms such as cough, nasal congestion, fever, body aches, sore throat, and malaise. However, certain cases present with diarrhea, difficult or labored breathing, chest pain, and in more severe cases acute cardiac injury, acute respiratory distress syndrome, pneumonia, and death 5, 6 . Populations at high risk include those with, hypertension, diabetes, preexisting cardiorespiratory conditions, asthma, autoimmune conditions, and those above the age of 70 7 .The current situation is unpredictable, as our In the absence of a vaccine and specific pharmaceutical treatments, the COVID-19 pandemic necessitates refinement in prophylactic strategies of the general population to reduce the spread and improve individual resilience to infection. Cross sectional and longitudinal data suggest that individuals who engage in regular moderate intensity exercise maintain a reduced risk of self-reported respiratory symptoms [8] [9] [10] and show improvements in mucosal immunity biomarkers 8, 11, 12 associated with lower risk of infection 8, 11, 13, 14 . Animal models from our group 15 and others 16, 17 have demonstrated that moderate intensity exercise performed before infection 15, 16 or infectious symptoms 17 , can reduce respiratory virus-associated mortality and severity of symptoms. However, the "dose" of exercise is important, as prolonged and unusually high intensity exercise before or during infection has been associated with increased morbidity and mortality [18] [19] [20] , especially in those naïve to such exercise. Although controversial 21, 22 , , according to the J curve hypothesis, while optimal doses of exercise lower the risk of respiratory infections, prolonged/intense exercise may significantly increase the risk of infections ( Figure   1 ).

The goals of this review are to discuss host immune defense against respiratory viral infections and highlight non-pharmaceutical prophylactic and health maintenance guidelines for the general population. We will provide observational and mechanistic evidence suggesting strategic amounts of exercise may be a valuable addition by aiding in prevention and strengthening immune defense against viral respiratory pathogens. Due to the recency of SARS-CoV-2 discovery, research cited in this review will not be specific to that pathogenic strain, but generalized to known viral respiratory infections.

Most acute respiratory infections are caused by RNA viruses belonging to the families Picornaviridae, Coronaviridae, Paramyxoviridae, and Orthomyxoviridae. Representative viruses belonging to these families are depicted in Table 1 . Infection of otherwise healthy individuals by these viruses occurs early and often during life and is characterized by relatively minor symptoms that are perceived mostly as inconvenient. However, respiratory viral pathogens are capable of causing high morbidity and mortality in susceptible populations such as children, the elderly, or those with pre-existing conditions and SARS-CoV-2 is no exception.

Members of the viral family Coronaviridae contain large positive sense single-stranded RNA genomes (~30-32 kb) and possess a characteristic crown-like appearance when viewed by electron microscopy. Infection of non-immunosuppressed people by seasonal human coronavirus (HCoV) strains HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1 causes relatively mild upper-respiratory illness. In fact, it is estimated that these HCoVs account for approximately 15-30% of 'common cold' illnesses 23 . However, during the last few decades three highly pathogenic novel strains of coronavirus have emerged that represent a serious threat to global health. In particular, severe acute respiratory syndrome (SARS)-CoV, SARS-CoV-2 (the virus responsible for COVID- 19) , and Middle East respiratory syndrome virus (MERS)-CoV are highly infectious diseases capable of causing high mortality.

Aside from respiratory illness, HCoV-OC43, HCoV229E, SARS-CoV, MERS and SARS-CoV-2 are also capable of invading the central nervous system and potentially infecting neuronal cell populations 24, 25 . Neurological manifestations have been associated with each of these strains, and are more prevalent amongst the more virulent SARS and MERS strains 26 . The neuroinvasive potential of HCoVs is not entirely surprising since other CoV strains have been J o u r n a l P r e -p r o o f known to do so for decades. In particular, the murine betacoronavirus mouse hepatitis virus (MHV) strains A59 and JHM are neurotropic and are established models for the human disease multiple sclerosis 27 . Indeed, mounting evidence suggest that infections by both SARS-CoV and SARS-CoV-2 are associated with the occurrence of encephalopathy, para-/postinfectious inflammatory CNS/PNS syndromes (i.e. acute disseminated encephalomyelitis and Gillian Bare syndrome), (meningo-)encephalitis, and neuropsychiatric complications. Additionally SARS-CoV and SARS-CoV-2 infections are also linked to the development of cardiovascular disease 26 .

There are only a limited number of FDA-approved drug targets against RNA viruses and they are only prescribed after the onset of symptoms. No vaccines are currently approved for rhinovirus, HCoV, or RSV. Therefore, these is a need to discover and explore alternative strategies that can be implemented to control morbidity and mortality. Such strategies would be beneficial if: 1) similar mechanisms control the generation of immunity towards respiratory viral infection, and 2) the strategy could bolster beneficial immune responses or enhance viral clearance without increasing morbidity.

Figure 2 depicts the immune response to respiratory viruses. The respiratory tract is constantly exposed to environmental (dust, pollution) and pathogenic (bacteria, viral, fungal)

insults, yet under normal circumstance is remarkably able to maintain homeostasis. This feat is attributable, in part, to ciliated epithelial cell barriers, but also to the presence of an elaborate mucosal immune system comprised of numerous cells including: resident alveolar macrophages (AM), interstitial macrophages (IM), nerve and airway associated macrophages (NAM), plasmacytoid dendritic cells (pDCs), conventional dendritic cells (cDC), conventional natural J o u r n a l P r e -p r o o f killer (NK) cells, innate lymphoid cell subsets (ILC1, ILC2, ILC3), and tissue resident memory T and B cells. Several excellent reviews on the specific functions of these cells have recently been published 28, 29 . Of importance here is that these cells are able to perceive the threat of viral infection and to respond appropriately. Viral RNA is recognized by the cytosolic pathogen recognition receptors (PRRs) retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA-5) as well as the endosomal toll-like receptors (TLR) TLR3, TLR7, TLR8 and TLR9. Importantly, these PRRs are not only expressed by macrophages and dendritic cells, but are also expressed in lung epithelial cells and memory lymphocyte cell populations 30 . Activation of these receptors by viral pathogen associated molecular patterns culminates in the production of the proinflammatory cytokines TNF-α, IL-1β, IL-6, and IL-12, the chemokines C-C motif ligand (CCL)2 , CCL5, C-X-C motif ligand (CXCL)10, and type I (IFNα, IFNβ) and III (IFNλ) interferons, which are critical for interfering with viral replication. Lung macrophages and DCs function to phagocytose debris and dying cells as well as facilitate immune response generation by means of antigen processing and presentation to adaptive T and B lymphocytes. Dendritic cells from the respiratory tract present antigens to lymphocytes within the nasal-associated lymphoid tissue (NALT), bronchus-associated lymphoid tissue (BALT), and mediastinal lymph nodes. In cDC's, PRR activation induces cell maturation characterized by upregulation of surface co-receptors CD80 and CD86. Binding of these co-receptors to CD28 on T cells and is required for efficient priming.

Data generated from animal and human studies indicates that MDA-5 and TLR3 are essential for recognizing rhinoviruses [31] [32] [33] [34] . Studies using murine hepatitis virus, the prototypical β-coronavirus, indicate MDA-5 and TLR7 are important for IFN production and protection J o u r n a l P r e -p r o o f against infection [35] [36] [37] . In contrast, TLR2/6 and TLR3 are needed for cytokine and chemokine production following RSV infection [38] [39] [40] . Finally, influenza viral RNA is recognized by TLR7, TLR8 and RIG-I [41] [42] [43] [44] [45] . Activation of different PRRs is needed for the recognition of pneumotropic viruses. It is notable that stimulation by each ultimately culminates in a global transcriptional response that is shared. Recently, an integrated transcriptomic analysis of multiple patient cohorts derived from controls or patients infected by rhinovirus, RSV, and influenza viruses identified 396 genes distinctive genes, termed the meta-virus signature (MVS) that is shared between respiratory viral infections. The MVS was also found to be specific in predicting respiratory viral infection resulting from SARS-CoV, and was able to distinguish between infections caused by bacteria. While responses are not identical between different viruses, these data do indicate that conserved immune responses occur in response to respiratory infection by RNA viruses that may be exploited for therapeutic benefit 46 . For instance, the requirement of TLR7 in the recognition of SARS-CoV-2 in humans is reinforced by the finding that single nucleotide polymorphisms in TLR7 are predictive of poor prognosis and mortality 47 49, 50 . However, unlike cNK cells, ILC1s lack perforin and granzyme B and therefore lack the capacity to lyse target cells 50 . The ability for NK cells to lyse virally infected targets is conveyed by through the recognition of activation receptors expressed targets during cellular stress, suppression of inhibitory receptor signaling and by IgG1 or IgG3 activation of FcRVIII (antibody dependent cell mediated cytotoxicity; ADCC) 51 . Regarding the latter, a recent longitudinal study showed that increased levels of antibodies capable of facilitating ADCC decreases susceptibility to influenza infection 52 Furthermore, patients with primary NK cell deficiency have increased risk for viral infection 55 including those of the respiratory tract 56 . Current evidence suggests that NK cells might be dysfunctional in SARS-CoV-2 patients and that this may contribute to disease exacerbation 53 .

Specifically, NK cells are reduced in the circulation of persons infected with SARS-CoV-2 and that their effector function might be impaired 57, 58 .

The polarization of naïve CD4 + helper T cells toward specific subsets, namely Th1, Th2, Th17, Treg and Tfh, is essential for directing immune responses against specific pathogens. Of these subsets, Th1 and Tfh cells are important for the generation of efficient viral immunity 59 .

Virus-specific CD4 + Th1 cells are generated from naïve T cells following T cell receptor recognition of MHC class II presented antigens, co-stimulation by activated APCs as well as stimulation by IL-12. These cells are characterized by the production IFNγ, TNF and IL-2, which aid in viral clearance and provide help to cytotoxic CD8 + T cells (CTLs). Cytotoxic T cells J o u r n a l P r e -p r o o f recognize foreign epitopes presented by MHC class I molecules and play an important role in viral clearance through the production of cytokines such as IFNγ as well as by directly lysing infected targets 59 . Not only do these cells participate in viral clearance, but preexisting virusspecific cells have been shown to correlate with protection from infection 60, 61 . The Tfh cell subset is a specialized cell subset that is generated in the presence of high levels IL-6 and IL-21.

Tfh cells are required for germinal center formation and function and thus have a major role in the processes of affinity maturation and class switching in B cells 62 . While Tfh cells are important, it is notable that, in mouse studies, IFNγ production by Th1 cells can also promote class switching and the generation of neutralizing antibodies to IAV in the absence of Tfh cells, indicating some compensatory mechanisms exist 63 .

The generation of high affinity antibody of the correct isotype is important for immunity to respiratory viral infections as they act to directly neutralize virus receptor interactions, promote opsonization and antigen presentation, facilitate antibody dependent cell mediated cytotoxicity and complement mediated cell lysis. Interestingly, Heinonen et al., examined differences between immune cell profiles and leukocyte transcriptomes between age-matched healthy control infants, RSV infected infants with a mild infection, and infected infants requiring hospitalization. Their results suggest that the phenotypic and transcriptomic signature of mild RSV infection was characterized by an increase in IFN and plasma cell genes compared with patients with severe infection 64 . Moreover, the therapeutic efficacy of monoclonal antibodies with paratopes specific for G and F to minimize symptoms of disease in passively immunized children also provides support [65] [66] [67] . Antibodies specific for the influenza lipid membrane protein haemagglutinin (HA) are directly neutralizing, but antibodies with specificity to neuraminidase (NA) and matrix (M)2 protein also confer protection. In humans, influenza-specific antibody 

Severe respiratory viral infections caused by influenza, SARS or MERS can be lethal.

Mortality is influenced by virus-intrinsic factors such as virulence, and genetic factors of the host, but may also be attributable to dysregulated immune activation. For instance, Cynomolgus macaques infected with the influenza strain responsible for the 1918 pandemic exhibited increased viral replication, enhanced viral dissemination, increased lung pathology and aberrant changes to innate immune responses compared to a monkey infected with a conventional influenza virus (A/Kawasaki/173/01; K173) 73 . The dysregulated immune response is predictive of disease severity and death [73] [74] [75] [76] , is characterized by early and enhanced production of the proinflammatory cytokines IFNα, G-CSF, TNF, IL-1α, IL-6, CCL2, CCL3, IL-8, and CXCL10 and J o u r n a l P r e -p r o o f has been termed the "cytokine storm". Cytokine storm is also observed in SARS-CoV, MERS-CoV and SARS-CoV-2 infected patients and is associated with poor prognosis [77] [78] [79] . In fact, SARS-CoV-2 patients on ventilation or oxygen therapy had reduced percentage of death after receiving treatment with dexamethasone, a synthetic glucocorticoid and potent immunosuppressive molecule 80 . The consistent correlation between overt inflammation and clinical outcome has sparked interest into the molecular events and cellular sources responsible for initiating and perpetuating the cytokine storm, as these may prove to be clinically relevant.

Studies utilizing mouse-adapted and never-adapted strains of human influenza virus indicate that the cytokine storm is initiated by endothelial cells and can be suppressed by activation of sphingosine 1 phosphate (S1P 1 ) receptor signaling. In this study, leukocyte accumulation in the lung was dependent on cytokine and chemokine production and mortality was mitigated following treatment with S1P analogs [81] [82] [83] [84] . Recent experimentation using influenza has implicated interferon regulatory factor-5 (IRF-5) as essential for the generation of the cytokine storm 85 . It is notable that TLR7 can directly activate MyD88 and that IRF5 signaling is a downstream target of MyD88. The transcription factor IRF-5 appears to be crucial for cytokines storm generation as Irf5 knockout mice are resistant to uncontrolled cytokine/chemokine production and virus induced mortality 85 . Interestingly, activation of hexosamine biosynthesis pathway by excessive glucosamine enhanced cytokine production from influenza infected cells by a mechanism that was dependent on O-linked β-N-acetylglucosmine (O-GluNAc) transferase mediated O-GlcNAcylation of IRF-5 86 . These results might partially explain why patients with diabetes are at risk for mortality following SARS-CoV-2 infection and imply that management of in blood glucose by exercise may act decrease risk of serious complications during respiratory infection. Thus, TLR7 may play Janus-face role in the pathogenesis of COVID-19, in that it is J o u r n a l P r e -p r o o f required for efficient viral recognition and initial IFN production, but aberrant activation may prove detrimental.

Epidemiologic Studies. The exercise immunology community has reached a consensus belief that regular bouts of moderate to vigorous intensity physical activity about an hour or less in duration is beneficial for the functioning of the immune system, and is probable to reduce risk of viral respiratory infections in the general population 21, 87 . A recent review article by Nieman and Wentz 20 compiled evidence from four recent epidemiological studies with sample sizes of 547 or greater. These studies demonstrated a 29% decreased illness risk when comparing upper versus lowest quartiles of physical activity 88 , an 18% decreased illness risk in high activity versus low activity groups 9 , a 43% decrease in total illness days in high vs lowest fitness tertiles 89 , and a 26% decreased risk of developing the common cold in high activity groups 90 .

Epidemiologic evidence to this point supports the consensus belief that physically active individuals are at lower risk of developing respiratory infection. The authors of all three above reports noted that certainty of the evidence was either low or very low due to variations in study design and insufficient sample size. Additionally, some included interventions contained exercise bouts longer than the generally recommended duration. Unfortunately, definitive assessment of viral load was not performed and the duration of the intervention was quite short.

Due to the difficulties of performing ethical human studies, many investigators have examined the effects of exercise on immune measures important in anti-viral defenses. Using this approach, some information about the effects of exercise on baseline host defense and susceptibility to viral infection can be gained. However, without tracking immune responses and outcomes to an actual viral infection, the approach provides only correlational data.

Along these lines, the important role of salivary immunoglobulin A (SIgA) in mucosal immunity have led to its investigation in relationship with respiratory infection and exercise; as it functions as a neutralizer and opsonin for antigens the host has previously been exposed. Spence et al. 106 tested for pathogens in athletes presenting upper respiratory infection symptoms and found that confirmed viral infections were only present in 30% of athletes reporting symptoms. These results suggest many symptoms indicative of an infection could be due to allergy or some other non-specific inflammatory stimuli. Evidence has revealed that only a small percentage of athletes experience recurrent infection symptoms 107 , an observation that has led to a search for common traits among susceptible individuals. Colbey et al. 108 found that athletes who reported symptoms for two or more days a month were high expressors of interferon alpha inducible protein 27 (IFI27). Cox et al. 109 found that athletes who self-reported three or more episodes of upper respiratory symptoms (URS) within a 12 month observation period were much more likely to be high expressers of IL-6 and low expressers of IL-4 (though not as robustly) than those who reported fewer than three episodes. IL-2 high expression genotype was also associated with decreased likelihood of frequent URS. Researchers noted they could not adjust for training volume. Zehsaz et al 110 found that male athletes with the IL-10-1082 high expression genotype were more likely to experience frequent URTI. Interestingly,

Gleeson et al. 101 found that antigen-stimulated whole blood culture of illness prone subjects produced IL-10 and IL-4 at rates 2.5 fold higher than the healthy group. At a P = 0.06, they also found higher production of IFN-γ and IL-2 in the illness-prone group. However, the production of IL-10 was significantly positively correlated with number of weeks with infection symptoms.

These findings suggest the phenomena of increased rate of URTI incidence among athletes with high training loads to be a complicated issue that warrants further investigation using genomic and transcriptomic approaches. More robust data and homogenous study designs are needed on salivary biomarkers in the general population and cytokine centered investigation to determine their relevance moving forward. The clinical relevance of exercise-induced changes in alpha amylase and lysozyme are also under investigated now 111 . Currently, the anti-inflammatory properties of Treg cells and IL-10 stand out as interesting targets of investigation.

Another strategy to address the actual immune response to a challenge in people involves assessing the impact of exercise on the immune response to a vaccination. While closer to addressing exercise's impact on a natural infection and informative, it is important to note that most vaccinations are administered intra-muscularly, which is not the route of infection for respiratory viruses. A study from our lab demonstrated that older adults engaged in moderate endurance exercise realized a longer lasting protective effect of the annual influenza vaccine such that they had protective antibody titers into March and April, whereas the control group did not 112 . A systematic review by Grande et al. 113 using a random effects model of six randomized trials totaling 599 participants revealed exercising immediately before influenza vaccination to be neither helpful nor harmful in the general adult population, but also noted that the analyzed data was of low quantity and quality with many design limitations. A flaw in this review was that it did not distinguish between regular and acute exercise before vaccination, which is often In support of the J curve hypothesis, athletes who regularly partake in prolonged endurance exercise (<90 min/session) may be at a higher risk of experiencing URS 20 . However, defining prolonged exercise as causative in this trend is a contentious topic among the exercise immunology community 21 . There is reason to believe that physiological states frequently associated with prolonged bouts of high intensity exercise (i.e. psychological stress, sleep deprivation, physical exhaustion, potential carbohydrate inadequacy) during competition periods cause transient immunosuppression, which may increase risk for respiratory infection 21 . While evidence attributing immunosuppression to prolonged exercise is equivocal, there is evidence in animal models (see more below) animals subjected to exhaustive exercise exhibit increased mortality rates in response to viral infection 18 . Of note, many of these studies utilized animals naïve to exercise (i.e. not trained). While animal models are limited in their interpretation, data of this nature presents the potential risk of unfamiliar and/or exhaustive exercise as exacerbating viral infection symptoms or risk of contraction in vertebrates. It is recommended to err on the J o u r n a l P r e -p r o o f safe side during a pandemic when the chance of becoming infected is abnormally high and the risk is relatively unknown, especially in those unaccustomed to intense, prolonged exercise. If one does partake in prolonged exhaustive exercise, the recommendation has been to maintain adequate consumption of carbohydrates as NK cell, T cell, and neutrophil functions have been reported to decline to a greater extent following exercise in a glycogen depleted state 20,99 . This is thought to be due to the larger stress response, causing greater cortisol, catecholamine, and IL-6 release 99 . Consumption of polyphenols has also been shown to attenuate some aspects of potential resultant immune suppression 20 .

Due to the obvious ethical concerns associated with properly controlled studies examining responses to specific pathogens in humans, we turn to animal models for the bulk of and display the ability of regular exercise to reduce severity of inflammatory responses in the lungs to an appropriate degree. In short, regular exercise reduced illness severity via decreased immune activity in lean mice, and via increased immune activity in obese mice. Exercise may help prevent the "cytokine storm" responsible for the excessive inflammatory response to Sars-CoV-2 infection, but human data are needed to make this conclusion.

There is a growing list of potential mechanisms potentially responsible for the effects exercise has on the immune system. Five recent review articles have compiled available experimental data that have found regular moderate intensity exercise can alter many immune biomarkers including reductions in senescent T-cells, increased T-cell proliferation and mobilization, lower systemic levels of pro-inflammatory cytokines preventing chronic inflammation, increased neutrophil phagocytosis leading to greater pathogen clearance, lowered inflammatory response to bacterial challenge, greater NK cell cytotoxicity indicating more effective clearance of MHC 1 presenting infected cells, increased IL-2 and IL-7 production 10, 22, 99, 117 , upregulated expression of CD28 on Th cells, muscular production of IL-6 118 , shifting the Th1/Th2 balance more towards Th2 dominance potentially reducing excessive inflammatory responses 117 , increasing antioxidant capacity leading to less free radical damage 119 , altered adipokine production to a less inflammatory profile 120 and hygiene initiatives, this number jumped to 75%. Addition of pharmaceutical antiviral treatment and prophylaxis further raised it to a 90% reduction. This effect was higher in workplaces than in the general population, with the effectiveness decreasing with higher virus . They also discovered a reduction in the peak daily attack rate in the five studies that reported it. The peaks were a median of 6 days later than a control group, although the variability was quite high. Fong et al. updated this with three additional published studies and found similar results but added that paid sick leave could improve compliance with regards to isolation of infected individuals 137 . A 16-month study of over 230 adult office workers demonstrated that employees exposed to individuals with symptoms of a respiratory tract infection were 5 times more likely to report a similar infection during the same week than those not exposed 138 supporting quarantine of exposed persons on a community level is "weak" because being able to identify infected individuals and their close contacts in a timely manner can be very laborious during early phases, and close to impossible during later phases of a pandemic 137 . School closings are efficacious, but timing and programming to ensure availability of non-academic resources are important. Closings should be done before the spread reaches its peak, and certain school associated resources, such as counseling and meals, need to be made available remotely to J o u r n a l P r e -p r o o f ensure proper physical and psychosocial development of children 140 . It is also important that school closings occur simultaneously with workplace measures allowing working from home, as this allows employees to take care of children 137 . Timely implementation and high levels of compliance were shown to be critical concerning social distancing policies combating influenza outbreaks 137 . There is also the potential for quarantine to have negative psychological effects on quarantined children and adults such as post-traumatic stress symptoms, confusion, and anger, illustrating an importance for assuring proper length, supplies, rationale, support systems, and information to those it affects 141 . Additional information on vehicle and airline travel and dynamics of transfer of respective viruses can further inform the most practical and efficacious methods of social distancing in outbreak situations for both the community and workplace.

Other Lifestyle Factors. Various other lifestyle choices have an impact on susceptibility to SARS-CoV-2 and COVID-19 disease. Importantly, poor lifestyle choices have been found to be exacerbated during the pandemic and subsequent lock down, perhaps due to the stress and isolation associated with the pandemic. In one study, 46% of respondents self-reported an increase in caloric intake and weight gain during confinement 142 . While primary data is scarce, there is also public health concern regarding the increased consumption of alcohol during the pandemic 143 to the extent that some countries have limited bans on alcohol sales 144 . There is little information on the risk for COVID-19 disease and alcohol use and underlying liver disease.

In one study, COVID-19 mortality was higher in patients with concomitant cirrhosis compared to controls, but the numbers of patients in the study were small 146 . In a systematic review and meta-analysis of 12 studies representing 2,794 patients, of whom 596 had severe disease, Del Sole et al found that smoking was associated with an overall higher risk level of 1.54 (95% CI 1.07-2.22) for severe COVID-19 disease 145 . More studies are needed, but most believe that there J o u r n a l P r e -p r o o f will be higher disease burden in smokers and alcoholics. As with most infectious diseases, malnutrition is both exacerbated by infection and a risk factor for poor outcomes 147 . Given that the pandemic started recently, there is little data on the role of poor diet on SARS-CoV-2 outcomes. Several dietary micronutrients, notably Vitamin A, Vitamin D, Vitamin E, Zinc and Selenium have shown significant influences on viral immune biomarkers 148 , making it important to ensure their regular and adequate consumption. An important caveat is that vitamin E supplementation has displayed deleterious effects in some populations 149 . More specifically, COVID-19 mortality rates have been linked to low levels of Vitamin D 150 and Selenium 151, 152 , and multiple associations have been drawn between vitamin D levels (or biomarkers thereof) and

other outcomes like infection rates 150 and illness severity 153 . Additionally, multiple clinical case reports have used zinc supplementation on admitted COVID-19 patients 154, 155 , with seemingly positive results, though more controlled and mechanistic evidence is needed to make specific conclusions 156 . Using evidence from other viral pathogens and candidate biomarkers, a review by Jayawardena et al. 148 Supports the notion that supplementation of vitamin D, zinc, and selenium may be beneficial in the prevention and treatment of COVID-19 infection. The authors further stated that supplementation of Vitamin A may help with COVID-19 prevention and treatment, and supplementation vitamin C may help with treatment alone. Supplementation of certain micronutrients may prove beneficial for COVID-19 outcomes, but further investigation is needed to assure this and determine appropriate doses. For maintenance of overall health, including protection from infectious diseases like COVID-19, it is always prudent to stop smoking, consume alcohol in moderation, and eat a healthy diet. It is also important to be aware that the response to the pandemic (i.e. confinement, stress) and the virus itself likely changes our behaviors in ways that might increase our susceptibility.

Overall, combinations of the above strategies have proved to be the most effective in terms of behavioral prophylaxis with the goal of delaying spread, reducing total number of cases, and delaying and reducing peak attack rate 136, 137, 157 . It may take an individual plan designed for each virus and time period/place to identify the most effective public health policies. Such policies should take into account infectious properties of the virus, current infection rates among the respective population, general economic and public health needs, and availability of resources. Additionally, increasing production of effective equipment such as N95 respirators and disinfecting agents could prevent the use of potentially ineffective alternatives.

This article has provided evidence to support the claim that multidisciplinary prophylactic approaches can aid in handling the COVID-19 pandemic. We believe it is advisable to enact widespread hygiene initiatives in all settings, carefully planned public social distancing policies, and extensive production and use of N95 respirators or other effective alternatives in addition to regular moderate intensity exercise. We hypothesize that many of the exerciseinduced benefits observed in viral respiratory infection outcomes will display external validity with respect to COVID-19, though the exact magnitude remains to be seen. Moderate intensity exercise training has shown merit in producing cytokine profiles indicative more appropriate inflammatory responses after viral respiratory infection. While unfamiliar and exhaustive exercise may not be unequivocally causative in the development of URTI, animal models suggest it may reduce individual resilience to infection and may be a high risk activity in light of the highly infectious nature of COVID-19. New technologies and research techniques will allow us to better characterize genetic components associated with frequent symptoms of URTI. Until J o u r n a l P r e -p r o o f there is more evidence on COVID-19 infected individuals specifically, more exact conclusions cannot be made.

The articles and studies cited in this interview are cited honestly and represented without fabrication or data manipulation. The manuscript has not been published and is not in review elsewhere.

All members contributed to literature review. NTH drafted the abstract, introduction, behavioral prophylaxis, Exercise as a Prophylactic and Adjunct Treatment Strategy, Effects of Exercise on Biomarkers of Anti-viral Immune Defense, animal models, mechanisms and conclusion. AS drafted the Human Respiratory Viruses section. JAW edited and contributed to all sections, and worked with NTH to assemble the manuscript.

The authors declare that they have no competing interests. 

Deaths: Final Data for 2013

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

The COVID-19 epidemic

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans

Moderate to vigorous physical activity and risk of upper-respiratory tract infection

The symptomatology of upper respiratory tract infections and exercise in elderly people

Variation of salivary immunoglobulins in exercising and sedentary populations

Effects of Pilates Exercise on Salivary Secretory Immunoglobulin A Levels in Older Women

Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes

Relationship between salivary IgA secretion and upper respiratory tract infection following a 160-km race

Effects of oat beta-glucan on innate immunity and infection after exercise stress

Exercise Improves Host Response to Influenza Viral Infection in Obese and Non-Obese Mice through Different Mechanisms

Moderate exercise protects mice from death due to influenza virus

Exercise, alveolar macrophage function, and susceptibility to respiratory infection

Nieman DC, and Wentz LM. The compelling link between physical activity and the body's defense system

Can exercise affect immune function to increase susceptibility to infection?

Debunking the Myth of Exercise-Induced Immune Suppression: Redefining the Impact of Exercise on Immunological Health Across the Lifespan

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans

Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43

Neurological manifestations of coronavirus infections -a systematic review

Coronavirus pathogenesis

Lung dendritic cells at the innateadaptive immune interface

group; TMCOcLcOcapLpasCdaCtaWgStw. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness

Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response

Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses

MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus

Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses

Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon

Host-Viral Interactions: Role of Pattern Recognition Receptors (PRRs) in Human Pneumovirus Infections

Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Speciesspecific recognition of single-stranded RNA via toll-like receptor 7 and 8

Recognition of single-stranded RNA viruses by Toll-like receptor 7

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I

Multi-cohort Analysis Identifies Conserved Transcriptional Signatures across Multiple Respiratory Viruses

Presence of Genetic Variants Among Young Men With Severe COVID-19

Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues

STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection

ILC1 Confer Early Host Protection at Initial Sites of Viral Infection

The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens

Cross-reactive antibody-dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission

Immunology of COVID-19: Current State of the Science

KLRD1-expressing natural killer cells predict influenza susceptibility

Emerging insights into human health and NK cell biology from the study of NK cell deficiencies

Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Helper T Cell Responses to Respiratory Viruses in the Lung: Development, Virus Suppression, and Pathogenesis

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Cellular immune correlates of protection against symptomatic pandemic influenza

T follicular helper cell differentiation, function, and roles in disease

Protective neutralizing influenza antibody response in the absence of T follicular helper cells

Immune profiles provide insights into respiratory syncytial virus disease severity iny young children

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

The human antibody response to influenza A virus infection and vaccination

T-bet+ Memory B Cells Link to Local Cross-Reactive IgG upon Human Rhinovirus Infection

Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates

Recovery from the Middle East respiratory syndrome is associated with antibody and Tcell responses

Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza

Lung pathology of fatal severe acute respiratory syndrome

MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile

COVID-19: consider cytokine storm syndromes and immunosuppression

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza

A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection

Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection

Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus

MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction

O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5

Position Statement Part one: Immune function and exercise

Upper respiratory tract infection is reduced in physically fit and active adults

Physical activity, stress, and self-reported upper respiratory tract infection

Smoking, leisure-time exercise and frequency of self-reported common cold among the general population in northeastern China: a cross-sectional study

Exercise versus no exercise for the occurrence, severity and duration of acute respiratory functions

Is the exercise effective for the prevention of upper respiratory tract infections?

6+ The Effect of Exercise on Prevention of the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies

Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial

The impact of exercise training on the lipid peroxidation metabolomic profile and respiratory infection risk in older adults

Assessment of immunological parameters following a qigong training program

The effect of exercise training on the severity and duration of a viral upper respiratory illness

Effect of exercise on upper respiratory tract infection in sedentary subjects

Chapter Fifteen -Exercise and the Regulation of Immune Functions

Variation of salivary immunoglobulins in exercising and sedentary populations

Respiratory infection risk in athletes: association with antigen stimulated IL-10 production and salivary IgA secretion

Mucosal IgA and URTI in American college football players: a year longitudinal study

Upper Respiratory Tract Infection Symptoms in Ultramarathon Runners Not Related to Immunoglobulin Status

Intense training: mucosal immunity and incidence of respiratory infections

The influence of an arduous military training program on immune function and upper respiratory tract infection incidence

Incidence, etiology, and symptomology of upper respiratory illness in elite athletes

Mucosal immunity, respiratory illness, and competitive performance in elite swimmers

Key Viral Immune Genes and Pathways Identify Elite Athletes with URS

Cytokine gene polymorphisms and risk for Upper Respiratory Symptoms in highly-trained athletes

IL-10 G-1082A gene polymorphism and susceptibility to upper respiratory tract infection among endurance athletes

Effects of exercise intensity on salivary antimicrobial proteins and markers of stress in active men

Cardiovascular Exercise Training Extends Influenza Vaccine Seroprotection in Sedentary Older Adults: The Immune Function Intervention Trial

Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults

Hallmarks of Improved Immunological Responses in the Vaccination of More Physically Active Elderly Females

Moderate exercise early after influenza virus infection reduces the Th1 inflammatory response in lungs of mice

Exercise and Respiratory Tract Viral Infections

Effects of Acute and Chronic Exercise on Immunological Parameters in the Elderly Aged: Can Physical Activity Counteract the Effects of Aging?

exercise and obesity: skeletal muscle as a secretory organ

The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis

The Immunomodulatory Effects of Physical Activity

The antiinflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease

An examination of the anxiolytic effects of exercise for people with anxiety and stressrelated disorders: A meta-analysis

Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation

Essential role of IL-10/STAT3 in chronic stress-induced immune suppression

Inflammation and metabolic disorders

Resolving a chronic inflammation mystery

A cluster randomized trial of cloth masks compared with medical masks in healthcare workers

Respiratory protection for healthcare workers treating Ebola virus disease (EVD): are facemasks sufficient to meet occupational health and safety obligations?

The efficacy of medical masks and respirators against respiratory infection in healthcare workers

A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in healthcare workers

Facemasks for the prevention of infection in healthcare and community settings

Impact of a Comprehensive Workplace Hand Hygiene Program on Employer Health Care Insurance Claims and Costs, Absenteeism, and Employee Perceptions and Practices

Impact of a hygiene intervention on virus spread in an office building

The healthy workplace project: Reduced viral exposure in an office setting

Aerosols and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review

Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures

Exposure to persons with symptoms of respiratory or gastrointestinal infection and relative risk of disease: self reported observations by controls in a randomized intervention trial

Initial Investigation of Transmission of COVID-19 Among Crew Members During Quarantine of a Cruise Ship -Yokohama

Mitigate the effects of home confinement on children during the COVID-19 outbreak

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Covid-19 and the Subsequent Lockdown Modified Dietary Habits of Almost Half the Population in an Italian Sample

Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder

Prohibiting alcohol sales during the coronavirus disease 2019 pandemic has positive effects on health services in South Africa

Features of severe COVID-19: A systematic review and meta-analysis

Poor outcomes in patients with cirrhosis and Corona Virus Disease-19

Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes and Metabolic Syndrome

Vitamin E and respiratory tract infections in elderly nursing home residents: A randomized controlled trial

The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality

Selenium Deficiency Is Associated with Mortality Risk from COVID-19

Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity

Association between regional selenium status and reported outcome of COVID-19 cases in China

Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients

Three Cases of COVID-19 Disease with Colonic Manifestations

Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raisint Anti-Viral Resistance Against Progressive COVID-19

Combination Strategies for pandemic influence response -a systematic review of mathematical modeling studies

J o u r n a l P r e -p r o o f

The authors declare that they have no competing interests.